Biopharmaceutical Analysis

Chris Spivey is the editorial director of 

Videos

Frontage Laboratories' Marianna Tcherpakov, PhD, director of Business Development, CMC Services, discussed the CDMO’s role in enabling startup biotechs solve complex technical challenges for scale up.

A Look at CDMO–Biotech Partnerships and Tackling Complex Technical Challenges (BIO 2024)

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Articles

Thermo Fisher Scientific's launch of its Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

Thermo Fisher Introduces New CDMO and CRO Services at CPHI Milan 2024

Contract organizations offer assistance for testing raw materials obtained from outside suppliers.

Contractors Support Material Testing

Contract organizations offer sponsors specialized equipment, capacity, and expertise for testing, manufacturing, and packaging bio/pharmaceutical products.

Contracting Out Frees Sponsors Up

Feliza Mirasol is the science editor for 

With the acquisition, Olink will join Thermo Fisher’s Life Sciences Solutions business.

Thermo Fisher Scientific Completes Olink Acquisition, Boosts Proteomics Capabilities

Daniel Radiloff, PhD, is director of Business Development, Pacific BioLabs.

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

The company is investing more than $2 million in its analytical testing services and adding suppository manufacturing capabilities.

LGM Pharma Expands Analytical Services

The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.

Nelson Labs Creates Center of Excellence for Parenteral and Ophthalmic Drug Manufacturing

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

Lonza and Oxford Nanopore Partner on mRNA Analytics

Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.

Contract Analytical Services